A Virtual Tutorial on Regulatory Pathways for Diagnostic Tests in the US and Europe

A Virtual Tutorial on Regulatory Pathways for Diagnostic Tests in the US and Europe

In this webinar, experts from Goldbug Strategies and Veranex discuss available regulatory pathways for bringing a new generation of innovative diagnostics to market in the United States and Europe. 

What’s Covered:

  • Regulation of clinical lab tests in the US 
  • US market entry considerations  
  • Regulation of clinical lab tests in the EU 
  •  Testing in clinical trials  
  • Q&A with representatives from PMC, Codex4SMEs, and EATRIS’ member networks  

Ready to dive in? Enter your information below to get the webinar and slide deck sent straight to your inbox.   

2 min read

The Regulatory Constraints in Making Your LDT/CDx Partnership Choices in China

Our previous blog discussed the emerging trends for the companion diagnostics (CDx) regulations in China. There have been several developments...

Read More